Sign in

CIK 0001752828

  • Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831702591
Phone
+1 908-768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. 4 Open-market buy Chief Executive Officer bought 40,000 shares at $1.74 ($69,600)
  2. 4 Shares withheld for taxes Chief Business Officer gave up 3,734 shares (to pay taxes)
  3. 4 Shares withheld for taxes General Counsel gave up 1,262 shares (to pay taxes)
  4. 4 Shares withheld for taxes Glover Bradley gave up 3,734 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Exercise or conversion Director acquired 768,594 shares (option exercise)
  8. 4 Exercise or conversion Chief Executive Officer acquired 119,073 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 36,145 shares (grant or award)
  11. 4 Grant or award Director acquired 36,145 shares (grant or award)
  12. 4 Grant or award Director acquired 36,145 shares (grant or award)
  13. 4 Grant or award Director acquired 36,145 shares (grant or award)
  14. 4 Grant or award Chief Technology Officer acquired 13,124 shares (grant or award)
  15. 4 Grant or award Director acquired 36,145 shares (grant or award)
  16. 4 Grant or award Director acquired 36,145 shares (grant or award)
  17. 4 Grant or award Chief Business Officer acquired 11,483 shares (grant or award)
  18. 4 Grant or award General Counsel acquired 2,297 shares (grant or award)
  19. 4 Grant or award Director acquired 36,145 shares (grant or award)
  20. 4 Grant or award Director acquired 36,145 shares (grant or award)

Page 6 of 10 · 191 filings